LIXTE BIOTECHNOLOGY HOLDINGS Director Yun Yen's 2023 pay slips 16% to $78K
LIXTE BIOTECHNOLOGY HOLDINGS reports 2023 executive compensation
By ExecPay News
Published: November 4, 2024
LIXTE BIOTECHNOLOGY HOLDINGS reported fiscal year 2023 executive compensation information on November 4, 2024.
In 2023, five executives at LIXTE BIOTECHNOLOGY HOLDINGS received on average a compensation package of $71K, a 33% decrease compared to previous year.
Average pay of disclosed executives at LIXTE BIOTECHNOLOGY HOLDINGS
Yun Yen, Director, received $78K in total, which decreased by 16% compared to 2022. 62% of Yen's compensation, or $48K, was in option awards. Yen also received $30K in other compensation.
Regina Brown, Director, received a compensation package of $78K, which decreased by 16% compared to previous year. 62% of the compensation package, or $48K, was in option awards.
Stephen J. Forman, Director, earned $71K in 2023, a 18% decrease compared to previous year.
Bas van der Baan, Director, received $67K in 2023, which decreases by 61% compared to 2022.
René Bernards, Director, earned $63K in 2023, a 53% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on November 4, 2024.